|
Powered by Cell Signaling Technology |
| Site Information |
|---|
| KRKLPCDtPGQGLtC SwissProt Entrez-Gene |
| Blast this site against: NCBI SwissProt PDB |
| Site Group ID: 454110 |
| In vivo Characterization | |
|---|---|
| Methods used to characterize site in vivo: | |
| Disease tissue studied: | |
| Relevant cell line - cell type - tissue: | |
| Upstream Regulation | |
|---|---|
| Regulatory protein: | |
| Kinases, in vitro: | |
| Putative upstream phosphatases: | |
| Treatments: | |
| Downstream Regulation | |
|---|---|
| Effects of modification on SRC-3: | |
| Effects of modification on biological processes: | |
| Inhibit interaction with: | |
| References | |
|---|---|
|
Wang X, et al. (2021) Therapeutic targeting of nemo-like kinase in primary and acquired endocrine-resistant breast cancer. Clin Cancer Res
33542078 Curated Info |
|
|
Nikolai BC, et al. (2016) HER2 Signaling Drives DNA Anabolism and Proliferation through SRC-3 Phosphorylation and E2F1-Regulated Genes. Cancer Res 76, 1463-75
26833126 Curated Info |
|
|
Foulds CE, et al. (2013) Proteomic Analysis of Coregulators Bound to ERα on DNA and Nucleosomes Reveals Coregulator Dynamics. Mol Cell 51, 185-99
23850489 Curated Info |
|
|
Kettenbach AN, et al. (2011) Quantitative phosphoproteomics identifies substrates and functional modules of aurora and polo-like kinase activities in mitotic cells. Sci Signal 4, rs5
21712546 Curated Info |
|
|
Li C, et al. (2008) Essential phosphatases and a phospho-degron are critical for regulation of SRC-3/AIB1 coactivator function and turnover. Mol Cell 31, 835-49
18922467 Curated Info |
|
|
Wu RC, et al. (2004) Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. Mol Cell 15, 937-49
15383283 Curated Info |